Tag: Soliris

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Soliris

Soliris Market Strategic Assessment & SWOT Analysis 2022-2028 | Alexion,,,,,, and more

Added to Collection on: 2022-07-04 20:26:50

Tags for this article:

Business process
Articles
Business
Marketing
Eculizumab
Immunosuppressants
Market structure
Market research
Atypical hemolytic uremic syndrome
Market segmentation
Market share
Marketing strategy
Soliris

Click the tags to see associated articles and topics

View Article Details
SOLIRIS PMPRB redetermination proceeding resolved on consent - JD Supra

Added to Collection on: 2022-08-30 15:32:24

Tags for this article:

Eculizumab
Immunosuppressants
Drugs
Patent
Health care
Health
Alexion Pharmaceuticals
Soliris

Click the tags to see associated articles and topics

View Article Details
Soliris Intravenous Market worth $7.3 billion by 2027 -Alexion - The Sports Forward

Added to Collection on: 2022-10-15 12:42:51

Tags for this article:

Eculizumab
Immunosuppressants
Atypical hemolytic uremic syndrome
Market research
Medicine
Medical specialties
Health care
Soliris

Click the tags to see associated articles and topics

View Article Details
AstraZeneca expands global footprint in rare disease with availability of first Alexion ... - Cision News

Added to Collection on: 2022-11-11 07:19:06

Tags for this article:

Medical specialties
Medicine
Health
Rare diseases
Blood disorders
Acquired hemolytic anemia
Alexion Pharmaceuticals
Eculizumab
Atypical hemolytic uremic syndrome
Paroxysmal nocturnal hemoglobinuria
Hemolytic anemia
Neuromyelitis optica
Soliris
Alexion Pharmaceuticals Inc.
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca bringing rare disease medicine to patients in China - BioPharma-Reporter

Added to Collection on: 2022-11-14 18:22:21

Tags for this article:

Medical specialties
Medicine
Rare diseases
Organ systems
Blood disorders
Acquired hemolytic anemia
Autoimmune diseases
Atypical hemolytic uremic syndrome
Syndromes
Eculizumab
Paroxysmal nocturnal hemoglobinuria
Hemolytic–uremic syndrome
Soliris

Click the tags to see associated articles and topics

View Article Details
Global Soliris Market 2022 Research Analysis | Alexion - Eagle's Eye

Added to Collection on: 2022-12-05 18:04:56

Tags for this article:

Business
Articles
Economy
Eculizumab
Immunosuppressants
Market analysis
Atypical hemolytic uremic syndrome
Market research
Market segmentation
Value chain
Mergers and acquisitions
Market
Soliris

Click the tags to see associated articles and topics

View Article Details
SOLIRIS by AstraZeneca expected to drive market size of Generalized Myasthenia Gravis

Added to Collection on: 2024-04-04 17:19:01

Tags for this article:

Orphan drugs
Eculizumab
Immunosuppressants
GMG
Myasthenia gravis
Gravis
Myasthenia
Market research
Germany
France
Japan
DelveInsight Business Research LLP
United States
Italy
United Kingdom
Soliris
AstraZeneca
Spain

Click the tags to see associated articles and topics

View Article Details
FDA clears Amgen's Bkemv as first biosimilar of Soliris - Pharmaphorum

Added to Collection on: 2024-05-29 21:48:08

Tags for this article:

Orphan drugs
Monoclonal antibodies
Acquired hemolytic anemia
Immunosuppressants
Eculizumab
Hemolytic–uremic syndrome
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Amgen
Alexion Pharmaceuticals
United States
Soliris

Click the tags to see associated articles and topics

View Article Details
Amgen's rare-disease treatment biosimilar Bkemv gets FDA approval | Morningstar

Added to Collection on: 2024-05-29 10:54:38

Tags for this article:

Acquired hemolytic anemia
Blood disorders
Alexion Pharmaceuticals
AstraZeneca
Nephrology
Eculizumab
Hemolysis
Hemolytic–uremic syndrome
Thrombotic microangiopathy
Hematologic disease
Paroxysmal nocturnal hemoglobinuria
Amgen
Soliris

Click the tags to see associated articles and topics

View Article Details
Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults ... - Placera

Added to Collection on: 2024-07-23 17:05:58

Tags for this article:

Orphan drugs
Immunosuppressants
Monoclonal antibodies
Hematology
Rare diseases
Eculizumab
Paroxysmal nocturnal hemoglobinuria
Ravulizumab
Alexion Pharmaceuticals
Danicopan
Hemolytic anemia
Hemolysis
Soliris

Click the tags to see associated articles and topics

View Article Details